{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:13:09Z","timestamp":1755216789704,"version":"3.43.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:p>The diagnostic criteria for juvenile myelomonocytic leukemia have recently been revised to include clinical findings and RAS-pathway gene mutations per the 2016 World Health Organization Classification of Tumors of Hematopoietic and Lymphoid Tissues. Differing clinical behaviors have been observed in cases with <jats:italic toggle=\"yes\">CBL<\/jats:italic> versus other RAS-pathway gene (RAS-p) mutations, notably the patients with <jats:italic toggle=\"yes\">CBL<\/jats:italic> mutations can be self-limiting with spontaneous resolution. Additional clinical characteristics and histopathologic findings between these subsets are less well-described. We performed a retrospective search and identified cases with either <jats:italic toggle=\"yes\">CBL<\/jats:italic> or RAS-p mutations, as per targeted and\/or massively parallel sequencing. Eight patients had sufficient material for review, including cytogenetic studies and peripheral blood, bone marrow aspirate, and\/or biopsy with flow cytometry analyses. Three patients showed <jats:italic toggle=\"yes\">CBL<\/jats:italic> mutations and lower percentages of hemoglobin F and peripheral blood absolute monocyte counts, lesser degrees of leukocytosis compared with the RAS-p cohort, and normal megakaryocyte morphology and myeloblast immunophenotypes. Two of these patients were managed with observation only and experienced resolution of their disease. The patients with RAS-p mutations had severe thrombocytopenia, moderate to severe anemia, and experienced variable clinical outcomes. Abnormal megakaryocyte morphology and decreased numbers of megakaryocytes were seen in cases with RAS-p mutations. In addition, 3 of 4 cases with flow cytometry data demonstrated aberrant CD7 expression in myeloblasts. Our study is the first to identify morphologic and immunophenotypic differences between juvenile myelomonocytic leukemia cases with <jats:italic toggle=\"yes\">CBL<\/jats:italic> or RAS-p mutations, and further supports previous reports of significantly different clinical behaviors between these subsets of patients.<\/jats:p>","DOI":"10.1097\/mph.0000000000002149","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T10:12:02Z","timestamp":1616753522000},"page":"e819-e825","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Morphologic and Immunophenotypic Differences in Juvenile Myelomonocytic Leukemias With CBL and Other Canonical RAS-pathway Gene Mutations: A Single Institutional Experience"],"prefix":"10.1097","volume":"43","author":[{"given":"Rachel A.","family":"Mariani","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Jennings","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanxiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rukhmi","family":"Bhat","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hematology, Oncology, and Stem Cell Transplantation, Ann and Robert H. Lurie Children\u2019s Hospital, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunyou","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,3,23]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/sj.leu.2401342","article-title":"Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS)","volume":"13","author":"Hasle","year":"1999","journal-title":"Leukemia"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1046\/j.1365-2141.1998.00995.x","article-title":"Haemopoietic cell transplantation in children with juvenile myelomonocytic leukaemia","volume":"103","author":"MacMillan","year":"1998","journal-title":"Br J Haematol"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1182\/blood-2009-01-198416","article-title":"Mutations in CBL occur frequently in juvenile myelomonocytic leukemia","volume":"114","author":"Loh","year":"2009","journal-title":"Blood"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood-2009-06-226340","article-title":"Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia","volume":"115","author":"Muramatsu","year":"2010","journal-title":"Blood"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/jmg.2010.076836","article-title":"Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia","volume":"47","author":"Perez","year":"2010","journal-title":"J Med Genet"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ng.641","article-title":"Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia","volume":"42","author":"Niemeyer","year":"2010","journal-title":"Nat Genet"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood-2014-08-550483","article-title":"How I treat juvenile myelomonocytic leukemia","volume":"125","author":"Locatelli","year":"2015","journal-title":"Blood"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/asheducation-2018.1.307","article-title":"JMML genomics and decisions","volume":"2018","author":"Niemeyer","year":"2018","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1182\/blood-2009-12-260729","article-title":"Long-term survival after nonintensive chemotherapy in some juvenile myelomonocytic leukemia patients with CBL mutations, and the possible presence of healthy persons with the mutations","volume":"115","author":"Matsuda","year":"2010","journal-title":"Blood"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1182\/blood.V85.7.1742.bloodjournal8571742","article-title":"Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system","volume":"85","author":"Passmore","year":"1995","journal-title":"Blood"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3324\/haematol.2014.114595","article-title":"RAS diseases in children","volume":"99","author":"Niemeyer","year":"2014","journal-title":"Haematologica"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/ng.3400","article-title":"The genomic landscape of juvenile myelomonocytic leukemia","volume":"47","author":"Stieglitz","year":"2015","journal-title":"Nat Genet"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1182\/blood-2017-07-798157","article-title":"Integrated molecular profiling of juvenile myelomonocytic leukemia","volume":"131","author":"Murakami","year":"2018","journal-title":"Blood"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1093\/hmg\/ddu148","article-title":"Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis","volume":"23","author":"Flex","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R16-20250804","first-page":"3534","article-title":"Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)","volume":"89","author":"Niemeyer","year":"1997","journal-title":"Blood"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.arcped.2016.09.007","article-title":"Juvenile myelomonocytic leukemia: a three-case series","volume":"23","author":"Ghariani","year":"2016","journal-title":"Arch Pediatr"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/PAT.0000000000000328","article-title":"Reassessment of H&E stained clot specimens and immunohistochemistry of phosphorylated Stat5 for histological diagnosis of MDS\/MPN","volume":"47","author":"Tsuruyama","year":"2015","journal-title":"Pathology"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1038\/bcj.2013.56","article-title":"Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemia","volume":"3","author":"Hasegawa","year":"2013","journal-title":"Blood Cancer J"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/10428194.2015.1049164","article-title":"Flow cytometry as a diagnostic support tool in juvenile myelomonocytic leukemia","volume":"57","author":"Maioli","year":"2016","journal-title":"Leuk Lymphoma"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:10:35Z","timestamp":1754338235000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,23]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002149","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2021,3,23]]},"assertion":[{"value":"2020-05-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}